We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

77 ELEKTRONIKA

Develops, manufactures, and markets fully automated and semi-automated urine analyzers, blood glucose meters, rapid t... read more Featured Products: More products

Download Mobile App




Automated Urine Microscope Verified for Regional Laboratories

By LabMedica International staff writers
Posted on 03 Feb 2021
Print article
Image: The UriSed 3 PRO is a professional automated urine sediment analyzer with a revolutionary new optical system combining bright-field and phase contrast microscopy (Photo courtesy of 77 Elektronika)
Image: The UriSed 3 PRO is a professional automated urine sediment analyzer with a revolutionary new optical system combining bright-field and phase contrast microscopy (Photo courtesy of 77 Elektronika)
Automated Urine Microscopy examines a sample of urine under a microscope. It can check cells from the urinary tract, blood cells, crystals, bacteria, parasites, and cells from tumors. This test is often used to confirm the findings of other tests or add information to a diagnosis.

Automation of urine particle counting has become a clinical standard in medium-sized and large laboratories by means of flow cytometry or several types of image analyzers. Reliable implementation of those instruments requires utilization of reference procedures in their verification.

Clinical Chemists and Microbiologists from Helsinki University Hospital (Helsinki, Finland) carried out the primary verification with 463 urine specimens, and against urine culture on chromogenic agar plates with 396 parallel specimens. Nine secondary instruments were compared pairwise with the primary instrument. Both mid-stream collections (generally 90% of all specimens) and catheterized specimens were taken into the study, based on particle findings.

Specimens were chosen from routine analysis by UF-1000i instrument (Sysmex, Kobe, Japan) for verification of the primary (“Gold”) UriSed 3 PRO instrument (77 Elektronika, Budapest, Hungary) against reference visual microscopy during a 6-week period in September - October 2018. Comparisons to urine culture results were available for 396 parallel samples which were cultured by using automated inoculation with 1 µL loop (WASP automated microbiology instrument, COPAN Wasp, Brescia, Italy) on chromogenic agar plates (CHROMagar Orientation medium, CHROMagar, Paris, France) following incubation at 35 °C for 18 hours.

The scientists reported that relative imprecisions compared to Poisson distribution, R(CV), were estimated to be 1.0 for white blood cell (WBC) and 1.5 for red blood cell (RBC) counts, respectively. Spearman’s correlations against visual microscopy were rS = 0.94 for WBC, rS = 0.87 for RBC, and rS = 0.82 for squamous epithelial cell (SEC) counts. Agreement with visual microscopy (Cohen’s weighted kappa) was 0.94 for WBC, 0.89 for RBC, 0.88 for SEC, 0.59 for combined casts, and 0.49 for non-squamous epithelial cells (NEC). Bacteria were detected with a sensitivity of 90% and specificity of 39 against culture at 107 colony forming bacteria/L (CFB/L = 104 CFU/mL). Created flagging limits allowed automated reporting for 70-75 % of patient results.

The authors were able to install 10 UriSed 3 PRO instruments in a regional laboratory environment at HUSLAB, providing about 160,000 automated particle counts annually at 24/7 basis, thus satisfying both routine testing and emergency analysis of clinical samples. Analytical performance fulfilled the analytical performance specifications and expectations obtained from preliminary testing. The study was published on January 26, 2021 in the journal Clinica Chimica Acta.

Related Links:
Helsinki University Hospital
Sysmex
77 Elektronika
COPAN Wasp
CHROMagar

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Epstein-Barr Virus Test
Mononucleosis Rapid Test
New
FOB+Transferrin+Calprotectin+Lactoferrin Test
CerTest FOB+Transferrin+Calprotectin+Lactoferrin Combo Test

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.